Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 6, 2015, Pages

  Estcourt, Lise J ^a   Stanworth, Simon ^b   Doree, Carolyn ^a   Blanco, Patricia ^a   Hopewell, Sally ^c   Trivella, Marialena ^c   Massey, Edwin ^d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENT; ALL CAUSE MORTALITY; BACTEREMIA; CLINICAL EFFECTIVENESS; FUNGEMIA; GRANULOCYTE TRANSFUSION; HUMAN; INFECTION; INFECTION PREVENTION; MORTALITY RISK; NEUTROPENIA; NEUTROPHIL; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; ADULT; ADVERSE EFFECTS; BACTERIAL INFECTIONS; CAUSE OF DEATH; CHILD; COMPLICATION; GRANULOCYTE; LEUKOCYTE DISORDERS; LEUKOCYTE TRANSFUSION; META ANALYSIS; MYCOSES; PROCEDURES; TRANSPLANTATION;

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIAL INFECTIONS; CAUSE OF DEATH; CHILD; GLUCOCORTICOIDS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; LEUKOCYTE DISORDERS; LEUKOCYTE TRANSFUSION; MYCOSES; NEUTROPENIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85016649971     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005341.pub3     Document Type: Review

References (79)

1. Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. New England Journal of Medicine 1978;298(19):1052-7. [MEDLINE: 417248]
2. Ford JM, Cullen MH, Roberts MM, Brown LM, Oliver RTD, Lister TA. Prophylactic granulocyte transfusions: results of a randomized controlled trial in patients with acute myelogenous leukemia. Transfusion 1982;22(4):311-6.
3. Ford JM, Lucey JJ, Cullen MH, Tobias JS, Lister TA. Fatal graft-versus-host disease following transfusion of granulocytes from normal donors. Lancet 1976;2:837-40.
4. Gomez-Villagran JL, Torres-Gomez A, Gomez-Garcia P, Martinez-Guibelalde F, Velasco-Jimena F. A controlled trial of prophylactic granulocyte transfusions during induction chemotherapy for acute nonlymphoblastic leukemia. Cancer 1984;54(4):734-8. [MEDLINE: 6378355]
5. Mannoni P, Rodet M, Vernant JP, Brun B, Coquin-Radeau EI, Bracq C, et al. Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukaemia. Blood Transfusion and Immunohaematology 1979;22(5):503-17.
6. Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, et al. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage. Transfusion 2006;46(1):14-23. [MEDLINE: 16398726]
7. Petersen FB, Buckner CD, Clift RA, Nelson N, Counts GW, Meyers JD, et al. Prevention of nosocomial infections in marrow transplant patients: a prospective randomized comparison of systemic antibiotics versus granulocyte transfusions. Infection Control 1987;7(12):586-92.
8. Schiffer CA, Aisner J, Daly PA, Schimpff SC, Wiernik PH. Alloimmunization following prophylactic granulocyte transfusion. Blood 1979;54(4):766-74. [MEDLINE: 476300]
9. NCT00000581 Granulocyte Transfusion Study. Clinical.Trials.gov 1999:[Accessed 21st April 2015].
10. Strauss RG, Connett JE, Gale RP, Bloomfield CD, Herzig GP, McCullough, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. New England Journal of Medicine 1981;305(11):597-603. [MEDLINE: 6790985]
11. Sutton DMC, Shumak KH, Baker MA. Prophylactic granulocyte transfusions in acute leukemia. Plasma Therapy 1982;3(1):45-9.
12. Vij R, DiPersio JF, Venkatraman P, Trinkaus K, Goodnough LT, Brown RA, et al. Donor CMV serostatus has no impact on CMV viraemia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation. Blood 2003;101(5):2067-9.
13. NCT00000581 Granulocyte Transfusion Study. Clinical.Trials.gov 1999:[Accessed 21st April 2015].
14. Winston DJ, Ho WG, Young LS, Gale RP. Prophylactic granulocyte transfusions during human bone marrow transplantation. American Journal of Medicine 1980;68(6):893-7. [MEDLINE: 6247910]
15. Alave JB, Roor RK, Djerassi I, Evans AE, Gluckman SJ, MacGregor RR, et al. A randomised clinical trial of granulocyte transfusions for infection in acute leukemia. New England Journal of Medicine 1977;296(13):706-11. [MEDLINE: 320477]
16. Altrichter J, Sauer M, Kaftan K, Birken T, Gloger D, Gloger M, et al. Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study. Critical Care 2011;15(2):R82.
17. Ambinder EP, Button GR, Cheung T, Goldberg JD, Holland JF. Filtration versus gravity leukapheresis in febrile granulocytopenic patients: a randomized prospective trial. Blood 1981;57:836-41.
18. Atay D, Ozturk G, Akcay A, Yanasik M, Anak S, Devecioglu O. Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions. Journal of Pediatric Hematology/Oncology: Official Journal of the American Society of Pediatric Hematology/Oncology 2011;33(6):e220-5.
19. Baley JE, Stork EK, Warkentin PI, Shurin SB. Buffy coat transfusions in neutropenic neonates with presumed sepsis: A prospective randomised trial. Pediatrics 1987;80:712-9.
20. Bow EJ, Schroeder ML, Louie TJ. Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B. Canadian Medical Association Journal 1984;130:593-5.
21. Buckner CD, Clift RA, Thomas ED, Hersman J, Sanders JE, Stewart PS, et al. Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures. Infection 1983;11(5):243-50. [MEDLINE: 6417027]
22. Christensen RD, Rothstein G, Anstall HB, Bybee B. Granulocyte transfusions in neonates with bacterial infection, neutropenia and depletion of mature marrow neutrophils. Pediatrics 1982;70:1-6.
23. DRKS00000218 Transfusion of granulocytes for patients with febrile neutropenia (GRANITE). Deutsche Forschungsgemeinschaft 2011:[Accessed 24th April 2015].
24. Freireich EJ, Lichtiger B, Mattiuzzi G, Martinez F, Reddy V, Kyle WJ. A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients. Leukemia 2013;27(4):861-5.
25. NCT00968838 A study for leukemia patients with life-threatening infections. www.clinicaltrials.gov 2008 [Accessed 17th February 2015].
26. Herzig R, Herzig GP, Graw RG, Bull MJ, Ray KK. Successful granulocyte transfusion therapy for gram-negative septicemia. New England Journal of Medicine 1977;296(13):701-5.
27. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. New England Journal of Medicine 1975;292(15):762-6.
28. Ikemoto J, Yoshihara S, Fujioka T, Ohtsuka Y, Fujita N, Kokubunji A, et al. Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy. Transfusion 2012;52(12):2646-52.
29. Klastersky J. EORTC International Antimicrobial Therapy Project Group. Early granulocyte transfusions in high risk febrile neutropenic patients. Schweizerische Medizinische Wochenschrift 1983;113(Suppl 14):46-8.
30. NCT01932710 A feasibility study of prophylactic white blood cell transfusions. Clinical.Trials.gov 2013:[Accessed 21st April 2015].
31. Pammi M, Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD003956.pub2]
32. NCT00627393 Safety and effectiveness of granulocyte transfusions in resolving infection in people With neutropenia (The RING Study). www.Clinical Trials.gov 2008 [Accessed 17th February 2015].
33. Price TH. The RING study: a randomized controlled trial of GCSF stimulated granulocytes in granulocytopenic patients. Blood 2014;124(21):SCI-16.
34. Price TH, McCullough J, Ness P, Strauss RG, Pulkrabek SM, Harrison R, et al. A randomized controlled trial on the efficacy of high-dose granulocyte transfusion therapy in neutropenic patients with infection. Blood 2014;124(21):597.
35. Scali G, von Felten A, Fehr J, Sasuter C, Gmür J. Granulocyte substitution in febrile leukemia patients with bone marrow aplasia. 1. Results of a prospective study [Granulozytensubstitution bei febrilen leukamiepatienten in knochenmarkaplasie]. Schweizerische Medizinische Wochenschrift 1978;108(41):1583-5.
36. Peters C, Seidel MG, Northoff H, Moog R, Boehme A, Silling G, et al. Granulocyte transfusions for treatment or prophylaxis of severe infections in immunocompromized neutropenic patients - a randomized clinical trial. ASH Annual Meeting Abstracts 2006;108(11):2934.
37. Seidel MG, Peters C, Wacker A, Northoff H, Moog R, Boehme A, et al. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplantation 2008;42(10):679-84.
38. UMIN000014777 Study on safety and efficacy of granulocyte transfusion mobilized with G-CSF in related donor. UMIN Clinical Trials Registry 2014:[Accessed 24th April 2015].
39. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. American Journal of Medicine 1977;63:548-55.
40. Wheeler JG, Chauvenet AR, Johnson CA, Block SM, Dillard R, Abramson JS. Buffy coat transfusions in neonates with sepsis and neutrophil storage pool depletion. Pediatrics 1982;79:422-5.
41. Winston DJ, Winston G, Gale RP. Therapeutic granulocyte transfusions for documented infections - A controlled trial in ninety-five infectious granulocytopenic episodes. Annals of Internal Medicine 1982;97:509-15.
42. NCT01204788 Prophylactic white cell transfusions versus therapeutic white cell transfusions in patients with leukemia. www.Clinicaltrials.gov 2010 [Accessed 17th February 2015].
43. Bashir S, Cardigan R. Granulocyte concentrates: how can we assess their quality?. Transfusion Medicine 2003;13:245.
44. Bashir S, Stanworth S, Massey E, Goddard F, Cardigan R. Neutrophuil function is preserved in a pooled granulocyte component prepared from whole blood donations. British Journal of Haematology 2008;140:701-11.
45. Bennett CL, Evens AM, Andritsos LA. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. British Journal of Haematology 2006;135(5):642-50.
46. Dale DC, Liles WC, Llewelyn C, Rodger E, Price TH. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor and dexamethasone. Transfusion 1998;38:713-21.
47. Dale DC, Liles WC. Return of granulocyte transfusions. Current Opinion in Pediatrics 2000;12:18-22.
48. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
49. Engelfriet CO, Reesink HW. Granulocyte transfusions. Vox Sanguinis 2000;79:59-96.
50. Freireich EJ, Levin RH, Whang J, Carbone PP, Bronson W, Morse EE. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Annals of the New York Academy of Sciences 1964;113:1081-90.
51. Ghodsi Z, Strauss RG. Cataracts in neutrophil donors stimulated with adrenal corticosteroids. Transfusion 2001;41:1464-8.
52. Goldman JM, Madrigal JA, Pamphilon D. Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors. British Journal of Haematology 2006 December;8:155-60.
53. Gutierrez-Delgado F, Bensigner W. Safety of granulocyte colony-stimulating factor in normal donors. Current Opinion in Haematology 2001;8:155-60.
54. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
55. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
56. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
57. Hubel K, Dale D C, Engert A, Liles WC. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. Journal of Infectious Diseases 2001;183:321-8.
58. Illerhaus G, Wirth K, Dwenger A, Waller CF, Garbe A, Brass V, et al. Treatment and prohylaxis of severe infections in neutropenic patients by granulocyte transfusions. Annals of Hematology 2002;81:273-81.
59. Kerr JP, Liakopolou E, Brown J, Cornish JM, Fleming D, Massey E, et al. The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation. British Journal of Haematology 2003;123:114-8.
60. Klastersky J. Empirical treatment of sepsis in neutropenic patients. Hospital Medicine (London) 2001;62:101-3.
61. Kuijpers TW, Weening RS, Roos D. Clinical and laboratory work-up of patients with neutrophil shortage or dysfunction. Journal of Immunological Methods 1999;232:211-29.
62. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
63. Massey E, Harding K, Kahan BC, Llewelyn C, Wynn R, Moppett J, et al. The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma. Transfusion Medicine 2012;22(4):277-84.
64. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
65. Peters C, Minkov M, Matthes-Martin S, Potschger U, Witt V, Mann G, et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. British Journal of Haematology 1999;106:689-96.
66. Price TH, Bowden RA, Beockh M, Bux J, Nelson K, Liles WC, et al. Phase l/ll trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 2000;95:3302-9.
67. The Nordic Cochrane Centre. Review Manager (RevMan). Version 5.3. Copenhagen: The Cochrane Collaboration, 2014.
68. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
69. Stanworth S, Massey E, Brunskill S, Hyde C, Lucas G, Marks D, et al. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD005339]
70. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
71. Storring RA, Jameson B, McElwain TJ, Wiltshaw E. Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet 1977;2(8043):837-40. [MEDLINE: 72192]
72. Stovold E, Beecher D, Foxlee R, Noel-Storr A. Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram. Systematic Reviews 2014;3(1):54.
73. Strauss RG. Granulocyte (neutrophil) transfusion. Apheresis: Principles and Practice. Bethesda: AABB Press, 2003:237-52.
74. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; Vol. 8, issue 16. [DOI: 10.1186/1745-6215-8-16]
75. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. Journal of Clinical Apheresis 1996;11:1-9.
76. van Staa TP, Boulton F, Cooper C, Hagenbeek A, Inskip H, Leufkens HG. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. American Journal of Hematology 2003;72(4):248-54.
77. World Health Organization. International statistical classification of diseases and related health problems. 10th edition. Vol. 1. Geneva 1992.
78. Massey E, Paulus U, Doree C, Stanworth S. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD005341.pub2]
79. Paulus U, Massey E, Doree C, Brunskill S, Hyde C, Lucas G, et al. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD005341]